Novo Nordisk A/S ADR buy BMO Capital Markets
Start price
08.08.24
/
50%
€115.00
Target price
08.08.25
€146.66
Performance (%)
-61.04%
End price
09.08.25
€44.80
Summary
This prediction ended on 09.08.25 with a price of €44.80. Massive losses of -61.04% were the result for the BUY prediction by BMO_Capital_Markets. Dividends of €1.56 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 5.906% | 5.906% | -35.800% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% |
Comments by BMO_Capital_Markets for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target lowered by analysts at BMO Capital Markets from $170.00 to $160.00. They now have an "outperform" rating on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Stopped prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€85.40
23.12.24
23.12.24
€100.93
23.12.25
23.12.25
-47.66%
24.12.25
24.12.25
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€109.50
17.10.24
17.10.24
€144.14
17.10.25
17.10.25
-57.17%
18.10.25
18.10.25
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€137.00
25.06.24
25.06.24
€152.14
25.06.25
25.06.25
-57.88%
26.06.25
26.06.25
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€119.50
12.04.24
12.04.24
€153.17
12.04.25
12.04.25
-50.63%
13.04.25
13.04.25